{"task_id": "8e549b87410f6e75", "source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 208/464)", "text": ",\nhigh grade, proximal location\nGastric Cancer\n197\n\n--- Page 219 ---\nRelated Topics\nDyspepsia (p. 113)\nLeser Trelat Sign (p. 368)\nMALT (p. 177)\nMelena (p. 118)\nMANAGEMENT\nSTAGE IA\ngastrectomy (total or subtotal) with D1\ndissection\nSTAGE IB, II, III\n\u0002\nOPTION 1\nneoadjuvant ECF\u00033 (epirubicin, cis\nplatin, infusional 5 fluorouracil) + surgery + adju\nvant ECF\u00033; 43% of patients able to complete\ntreatment\n\u0002\nOPTION 2\ngastrectomy (total or subtotal) with\nD1 dissection + adjuvant chemoradiation (5\nfluorouracil)\n\u0002\nINSUFFICIENT\nEVIDENCE\nD2 dissection, adjuvant\nradiation alone, adjuvant chemotherapy alone,\nand neoadjuvant radiation\nSTAGE IV (T1 4N1 3M0)\nsame treatment approach\nas stage III if resectable disease. Otherwise, same\ntreatment approach as metastatic disease\nSTAGE IV (M1, MEDIAN SURVIVAL 10 MONTHS)\n\u0002\nPALLIATIVE\nCHEMOTHERAPY\nstandard\nregimens\ninclude ECF (E=epirubicin, C=cisplatin, F=infusional\n5 fluorouracil), DCF (D=docetaxel, C=cisplatin, F=5\nfluorouracil),\nECX,\nEOX,\nEOF\n(X=capecitabine,\nO=oxaliplatin). For patients with poor performance\nstatus, consider CF, FOLFIRI (5 fluorouracil leucov\norin irinotecan), 5 fluorouracil alone, or irinotecan\nalone. No standard for second line, which may\ninclude FOLFIRI, irinotecan alone, or taxane alone.\nRecent findings from the TOGA trial demonstrate\nimproved survival with the addition of trastuzumab\nto chemotherapy in HER2 positive gastric cancer\n(positivity rate 15 20%)\n\u0002\nPALLIATIVE\nRADIATION\nfor bony metastasis or\nbleeding tumors\n\u0002\nPALLIATIVE\nSURGERY\ngastrojejunostomy,\npartial\ngastrectomy to bypass obstruction\nTREATMENT ISSUES\nVITAMIN B12 DEFICIENCY\nmay develop after a few\nyears in patients who received subtotal or total\ngastrectomy\nLYMPH NODE RESECTION\n\u0002 D1 dissection\nremoval of the stomach and less\nand greater omentum with the associated N1 peri\ngastric lymph nodes\n\u0002 D2 dissection\nD1 dissection, plus removal of N2\nlymph nodes, including a splenectomy and distal\npancreatectomy\nFOLLOW UP\nno agreed upon surveillance pro\ngram. q3month for first year, then every 6 months\nfor a total of 5 years. Endoscopy at 6 months, 18\nmonths, then every 2 3 years (variable guidelines)\nColorectal Cancer\nNEJM 2005 352:5\nPATHOPHYSIOLOGY\nCLASSIFICATION BY HISTOLOGY\n\u0002\nADENOCARCINOMA\nmucinous subtype, signet ring\ncells, adenosquamous, medullary\n\u0002\nCARCINOID\nmostly involving appendix and rec\ntum, less malignant\n\u0002\nRARE\nsquamous cell, small cell, undifferentiated\n\u0002\nADENOMATOUS POLYP\npre malignant\nRISK FACTORS\n\u0002\nPERSONAL\nage\n\u0002\nFAMILY\nHISTORY\naffected relatives (2\u0003), HNPCC\n(mutation in MSH 2, MLH 1, PMS 1, PMS 2, or MSH\n6 genes responsible for mismatch repair, 6% of all\ncolon cancers), familial adenomatous polyposis (1% of\nall colon cancers related to mutation in APC gene, all\naffected will have colon cancer by age 40), Peutz Je\nghers syndrome, juvenile polyposis, Gardner\u2019s syn\ndrome, Turcot\u2019s syndrome, flat adenoma syndrome\n\u0002\nENVIRONMENTAL\ndecreased fiber intake\nPATHOPHYSIOLOGY (CONT\u2019D)\n\u0002\nDISEASES\nprior colon cancer, polyps, ovarian,\nbreast, endometrial cancer, Crohn\u2019s, ulcerative coli\ntis (1%/year after 10 years), diabetes, obesity\nLOCATION\n50% rectosigmoid, 18% descending\ncolon, 11% transverse colon, 20% in the ascending\ncolon and cecum\nDISTINGUISHING FEATURES BETWEEN COLON\nAND RECTAL CANCER\nColon cancer\nRectal cancer\nFrequency\n2/3\n1/3\nLocation\n>12 cm\n[>4.7 in.]\nfrom anal\nverge or\nabove\nperitoneal\nreflection\n<12 cm\n[<4.7 in.]\nfrom anal\nverge or\nbelow\nperitoneal\nreflection\nMANAGEMENT (CONT\u2019D)\n198\nColorectal Cancer", "text_length": 3486, "metadata": {"source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 208/464)", "type": "chunk", "chunk_index": 207, "total_chunks": 464, "uploaded_by": "admin@admin.com", "upload_date": "2025-12-11T18:40:09.532189", "document_uuid": "fda2cab4-cdd9-4015-af24-46fd62c86d94", "filename": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf", "category": "medical_pdf", "section": "body", "year": null, "outdated": false, "document_id": "fda2cab4-cdd9-4015-af24-46fd62c86d94"}, "created_at": "2025-12-11T18:40:09.532943", "status": "complete", "chunks_added": 2}